Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2014 1
2015 6
2016 6
2017 6
2018 7
2019 10
2020 7
2021 13
2022 12
2023 14
2024 5

Text availability

Article attribute

Article type

Publication date

Search Results

77 results

Results by year

Filters applied: . Clear all
Page 1
Saccharomyces boulardii CNCM I-745: A Non-bacterial Microorganism Used as Probiotic Agent in Supporting Treatment of Selected Diseases.
Kaźmierczak-Siedlecka K, Ruszkowski J, Fic M, Folwarski M, Makarewicz W. Kaźmierczak-Siedlecka K, et al. Curr Microbiol. 2020 Sep;77(9):1987-1996. doi: 10.1007/s00284-020-02053-9. Epub 2020 May 29. Curr Microbiol. 2020. PMID: 32472262 Free PMC article. Review.
The yeast Saccharomyces boulardii CNCM I-745 is a unique, non-bacterial microorganism classified as a probiotic agent. ...Even though cases of fungemia following S. boulardii CNCM I-745 administration were reported, it should be treated a …
The yeast Saccharomyces boulardii CNCM I-745 is a unique, non-bacterial microorganism classified as a probiotic agent. …
Diversity of Saccharomyces boulardii CNCM I-745 mechanisms of action against intestinal infections.
Czerucka D, Rampal P. Czerucka D, et al. World J Gastroenterol. 2019 May 14;25(18):2188-2203. doi: 10.3748/wjg.v25.i18.2188. World J Gastroenterol. 2019. PMID: 31143070 Free PMC article. Review.
The yeast Saccharomyces boulardii CNCM I-745 is one of the probiotics recommended for the prevention of antibiotic-associated diarrhea. ...Oral administration of Saccharomyces boulardii CNCM I-745 to healthy subjects does not alter their …
The yeast Saccharomyces boulardii CNCM I-745 is one of the probiotics recommended for the prevention of antibiotic-asso …
Saccharomyces boulardii CNCM I-745 Improves Intestinal Enzyme Function: A Trophic Effects Review.
Moré MI, Vandenplas Y. Moré MI, et al. Clin Med Insights Gastroenterol. 2018 Feb 9;11:1179552217752679. doi: 10.1177/1179552217752679. eCollection 2018. Clin Med Insights Gastroenterol. 2018. PMID: 29449779 Free PMC article. Review.
Several properties of the probiotic medicinal yeast Saccharomyces boulardii CNCM I-745 contribute to its efficacy to prevent or treat diarrhoea. ...The administration of polyamines or S. boulardii CNCM I-745 enhances the expression of int …
Several properties of the probiotic medicinal yeast Saccharomyces boulardii CNCM I-745 contribute to its efficacy to pr …
Impact of Saccharomyces boulardii CNCM I-745 on Bacterial Overgrowth and Composition of Intestinal Microbiota in Diarrhea-Predominant Irritable Bowel Syndrome Patients: Results of a Randomized Pilot Study.
Bustos Fernández LM, Man F, Lasa JS. Bustos Fernández LM, et al. Dig Dis. 2023;41(5):798-809. doi: 10.1159/000528954. Epub 2023 Jan 11. Dig Dis. 2023. PMID: 36630947 Clinical Trial.
BACKGROUND: Small intestinal bacterial overgrowth (SIBO) is associated with diarrhea-predominant irritable bowel syndrome (IBS-D). Probiotics like Saccharomyces boulardii CNCM I-745 (Sb) may be efficacious in balancing the microbiota. This randomized open lab …
BACKGROUND: Small intestinal bacterial overgrowth (SIBO) is associated with diarrhea-predominant irritable bowel syndrome (IBS-D). Probiotic …
Randomized, direct comparison study of Saccharomyces boulardii CNCM I-745 versus multi-strained Bacillus clausii probiotics for the treatment of pediatric acute gastroenteritis.
Altcheh J, Carosella MV, Ceballos A, D'Andrea U, Jofre SM, Marotta C, Mugeri D, Sabbaj L, Soto A, Josse C, Montestruc F, McFarland LV. Altcheh J, et al. Medicine (Baltimore). 2022 Sep 9;101(36):e30500. doi: 10.1097/MD.0000000000030500. Medicine (Baltimore). 2022. PMID: 36086703 Free PMC article. Clinical Trial.
Our aim was to compare the efficacy and safety of 2 probiotics (Saccharomyces boulardii CNCM I-745 vs a 4-strain mixture of Bacillus clausii O/C, SIN, N/R, T) for the treatment of PAGE. ...A total of 317 children were enrolled and blindly randomized to 5 days …
Our aim was to compare the efficacy and safety of 2 probiotics (Saccharomyces boulardii CNCM I-745 vs a 4-strain mixtur …
Unique Properties of Yeast Probiotic Saccharomyces boulardii CNCM I-745: A Narrative Review.
Gopalan S, Ganapathy S, Mitra M, Neha, Kumar Joshi D, Veligandla KC, Rathod R, Kotak BP. Gopalan S, et al. Cureus. 2023 Oct 1;15(10):e46314. doi: 10.7759/cureus.46314. eCollection 2023 Oct. Cureus. 2023. PMID: 37927652 Free PMC article. Review.
S. boulardii CNCM I-745 being considered a safe probiotic for use in children and adults also finds recommendations in several international guidelines for the management of acute diarrhea. The current review discusses evidence for the proven efficacy and saf …
S. boulardii CNCM I-745 being considered a safe probiotic for use in children and adults also finds recommendations in …
Saccharomyces boulardii CNCM I-745 in different clinical conditions.
Dinleyici EC, Kara A, Ozen M, Vandenplas Y. Dinleyici EC, et al. Expert Opin Biol Ther. 2014 Nov;14(11):1593-609. doi: 10.1517/14712598.2014.937419. Epub 2014 Jul 4. Expert Opin Biol Ther. 2014. PMID: 24995675 Review.
AREAS COVERED: The objective of the present report is to provide an update on the evidence for the efficacy of S. boulardii CNCM I-745 in different clinical conditions. Saccharomyces boulardii is one of the best-studied probiotics in acute gastroenteritis (AG …
AREAS COVERED: The objective of the present report is to provide an update on the evidence for the efficacy of S. boulardii CNCM I …
[Saccharomyces boulardii CNCM I-745 influences the gut-associated immune system].
Stier H, Bischoff SC. Stier H, et al. MMW Fortschr Med. 2017 Jun;159(Suppl 5):1-6. doi: 10.1007/s15006-017-9802-3. Epub 2017 Jun 22. MMW Fortschr Med. 2017. PMID: 28643294 Review. German.
BACKGROUND: The impact of the intestinal microbiome is increasing steadily with regard to the immune function und the defense against pathogens. The medicinal yeast Saccharomyces boulardii CNCM I-745 (S. boulardii) has been used as probiotic for the preventio …
BACKGROUND: The impact of the intestinal microbiome is increasing steadily with regard to the immune function und the defense against pathog …
Beneficial effects of Saccharomyces boulardii CNCM I-745 on clinical disorders associated with intestinal barrier disruption.
Terciolo C, Dapoigny M, Andre F. Terciolo C, et al. Clin Exp Gastroenterol. 2019 Feb 11;12:67-82. doi: 10.2147/CEG.S181590. eCollection 2019. Clin Exp Gastroenterol. 2019. PMID: 30804678 Free PMC article. Review.
Such a compromised intestinal barrier is the main factor underlying the pathogenesis of inflammatory bowel disease, but also commonly occurs in various systemic diseases such as viral infections and metabolic syndrome. The non-pathogenic yeast Saccharomyces boulardii CNCM …
Such a compromised intestinal barrier is the main factor underlying the pathogenesis of inflammatory bowel disease, but also commonly occurs …
Saccharomyces boulardii CNCM I-745 supplementation during and after antibiotic treatment positively influences the bacterial gut microbiota.
Spatz M, Wang Y, Lapiere A, Da Costa G, Michaudel C, Danne C, Michel ML, Langella P, Sokol H, Richard ML. Spatz M, et al. Front Med (Lausanne). 2023 Aug 4;10:1087715. doi: 10.3389/fmed.2023.1087715. eCollection 2023. Front Med (Lausanne). 2023. PMID: 37601783 Free PMC article.
Here, we examined the effect of antibiotics (ATB) on the composition of bacterial and fungal microbiota and how the administration of Saccharomyces boulardii CNCM I-745 influences both microbiota. METHODS: In order to get closer to the human microbiota, the m …
Here, we examined the effect of antibiotics (ATB) on the composition of bacterial and fungal microbiota and how the administration of Saccha …
77 results